Snap Stories
Teva Stock Launches To A 5-Year High On An Important Development In Antipsychotics
Business
Teva stock surged to a five-year high Wednesday after the company beat first-quarter expectations and unveiled promising results from its schizophrenia treatment ...
Datadog Stock: Datadog Earnings Top Estimates. Revenue Outlook Underwhelms.
Business
Datadog (DDOG) on Tuesday reported first quarter earnings and revenue that topped estimates. The software maker’s guidance edged by views while the ...
AT&T Stock: Earnings, Free Cash Flow, Wireless Subscriber Adds Beat Views
Business
AT&T (T) early Wednesday reported first quarter earnings that fell from a year earlier but topped estimates. Revenue slightly missed. AT&T stock ...
Tesla Stock Could Hit New 52-Week Low After Downgrade On ‘Thesis-Changing’ Shift
Business
Tesla (TSLA) stock fell Thursday, marking a new 52-week low, as the global EV giant received a downgrade based on Chief Executive ...
Apple Stock Rises On AI Mac Report
Business
Apple (AAPL) stock rose in above-average trading volume for the second straight day on a news report that the company plans a ...
Google Stock: Google Cloud, AI Event Kicks Off With Arm, Palo Alto News
Business
Alphabet‘s (GOOGL) cloud computing event on Tuesday touted artificial intelligence partnerships and products that could give a boost to Google stock. Google ...
Tesla Stock: Bulls Turn Bearish As ‘Nightmare’ First Quarter Comes To An End
Business
Tesla (TSLA) bulls expect Q1 to be the first official disappointment of a difficult 2024 with the global EV giant heading toward ...
Palantir Stock Downgraded Amid ‘Unprecedented Generative AI Hype Cycle’
Business
An analyst downgraded data analytics software maker Palantir Technologies (PLTR) on Thursday on views its valuation is inflated amid investor buzz over ...
This Is The Ultimate Donald Trump Stock: Is DWAC A Buy Ahead Of Key Merger Vote?
Business
Donald Trump is one of the world’s most famous businessmen, but his companies have usually been privately held. Now investors have the ...
BioNTech Stock Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
Business
BioNTech (BNTX) stock tumbled to its lowest point in three years Wednesday after the Covid vaccine maker reported light fourth-quarter sales and ...
